Analysis of clinical trials using SAS: a practical guide

por Dmitrienko, Alex, Koch, Gary G
Publicado 2017

Categorical data analysis using the SAS system

por Stokes, Maura Ellen, Davis, Charles S, Koch, Gary G
Publicado 2000

Categorical data analysis using SAS

por Stokes, Maura Ellen, Davis, Charles S, Koch, Gary G
Publicado 2012

Pulmonary and cardiovascular safety of inhaled insulin in routine practice: The Exubera Large Simple Trial (VOLUME)

por Gatto, Nicolle M., Bracken, Michael B., Kolitsopoulos, Francesca, Duggan, William T., Koch, Gary G., Wise, Robert A., Jackson, Neville C.
Publicado 2019

Association of Anxiety and Depression With All‐Cause Mortality in Individuals With Coronary Heart Disease

por Watkins, Lana L., Koch, Gary G., Sherwood, Andrew, Blumenthal, James A., Davidson, Jonathan R.T., O'Connor, Christopher, Sketch, Michael H.
Publicado 2013

Noninvasive measure of treatment response in non‐alcoholic steatohepatitis: Insights from EMMINENCE and meta‐analysis

por Davison, Beth A, Edwards, Christopher, Loomba, Rohit, Harrison, Stephen A, Cotter, Gad, Alkhouri, Naim, Koch, Gary G, Dittrich, Howard C
Publicado 2021

Exploratory analyses of clinical trial data used for health technology assessments: a retrospective evaluation

por Oddens, Björn J, Agaku, Israel T, Snyder, Ellen S, Malbecq, William, Wang, William WB, Kaplan, Karen M, Koch, Gary G, Rockhold, Frank W
Publicado 2022

Design and Analysis of Studies Based on Hierarchical Composite Endpoints: Insights from the DARE-19 Trial

por Gasparyan, Samvel B., Buenconsejo, Joan, Kowalewski, Elaine K., Oscarsson, Jan, Bengtsson, Olof F., Esterline, Russell, Koch, Gary G., Berwanger, Otavio, Kosiborod, Mikhail N.
Publicado 2022

Oxidized LDL and Fructosamine Associated with Severity of Coronary Artery Atherosclerosis in Insulin Resistant Pigs Fed a High Fat/High NaCl Diet

por Nichols, Timothy C., Merricks, Elizabeth P., Bellinger, Dwight A., Raymer, Robin A., Yu, Jing, Lam, Diana, Koch, Gary G., Busby, Walker H., Clemmons, David R.
Publicado 2015

Association of Depression Symptoms and Biomarkers of Risk on Clinical Outcomes in HFrEF

por Sherwood, Andrew, Blumenthal, James A., Mentz, Robert J., Koch, Gary G., Rogers, Joseph G., Chang, Patricia P., Chien, Christopher, Adams, Kirkwood F., Rose-Jones, Lisa J., Jensen, Brian C., Johnson, Kristy S., Hinderliter, Alan, L.
Publicado 2023

Permutation criteria to evaluate multiple clinical endpoints in a proof-of-concept study: lessons from Pre-RELAX-AHF

por Davison, Beth A., Cotter, Gad, Sun, Hengrui, Chen, Li, Teerlink, John R., Metra, Marco, Felker, G. Michael, Voors, Adriaan A., Ponikowski, Piotr, Filippatos, Gerasimos, Greenberg, Barry, Teichman, Sam L., Unemori, Elaine, Koch, Gary G.
Publicado 2011

Effects of dapagliflozin on prevention of major clinical events and recovery in patients with respiratory failure because of COVID‐19: Design and rationale for the DARE‐19 study...

por Kosiborod, Mikhail, Berwanger, Otavio, Koch, Gary G., Martinez, Felipe, Mukhtar, Omar, Verma, Subodh, Chopra, Vijay, Javaheri, Ali, Ambery, Philip, Gasparyan, Samvel B., Buenconsejo, Joan, Sjöström, C. David, Langkilde, Anna Maria, Oscarsson, Jan, Esterline, Russell
Publicado 2021

Impact of cardiovascular risk enrichment on incidence of major adverse cardiovascular events in the tofacitinib rheumatoid arthritis clinical programme

por Dougados, Maxime, Charles-Schoeman, Christina, Szekanecz, Zoltán, Giles, Jon T, Ytterberg, Steven R, Bhatt, Deepak L, Koch, Gary G, Vranic, Ivana, Wu, Joseph, Wang, Cunshan, Kwok, Kenneth, Menon, Sujatha, Connell, Carol A, Yndestad, Arne, Rivas, Jose L, Buch, Maya H
Publicado 2023

Risk of major adverse cardiovascular events with tofacitinib versus tumour necrosis factor inhibitors in patients with rheumatoid arthritis with or without a history of atheroscler...

por Charles-Schoeman, Christina, Buch, Maya H, Dougados, Maxime, Bhatt, Deepak L, Giles, Jon T, Ytterberg, Steven R, Koch, Gary G, Vranic, Ivana, Wu, Joseph, Wang, Cunshan, Kwok, Kenneth, Menon, Sujatha, Rivas, Jose L, Yndestad, Arne, Connell, Carol A, Szekanecz, Zoltan
Publicado 2023

Dapagliflozin in patients with cardiometabolic risk factors hospitalised with COVID-19 (DARE-19): a randomised, double-blind, placebo-controlled, phase 3 trial

por Kosiborod, Mikhail N, Esterline, Russell, Furtado, Remo H M, Oscarsson, Jan, Gasparyan, Samvel B, Koch, Gary G, Martinez, Felipe, Mukhtar, Omar, Verma, Subodh, Chopra, Vijay, Buenconsejo, Joan, Langkilde, Anna Maria, Ambery, Philip, Tang, Fengming, Gosch, Kensey, Windsor, Sheryl L, Akin, Emily E, Soares, Ronaldo V P, Moia, Diogo D F, Aboudara, Matthew, Hoffmann Filho, Conrado Roberto, Feitosa, Audes D M, Fonseca, Alberto, Garla, Vishnu, Gordon, Robert A, Javaheri, Ali, Jaeger, Cristiano P, Leaes, Paulo E, Nassif, Michael, Pursley, Michael, Silveira, Fabio Serra, Barroso, Weimar Kunz Sebba, Lazcano Soto, José Roberto, Nigro Maia, Lilia, Berwanger, Otavio
Publicado 2021